CDRH / Shelhigh Inc. / GE OEC Medical Systems Inc. / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
paper systems / radiation emitting products / magnetic resonance imaging / device technology / improved management / care technology / sub-networks / targeted high-risk products / manufacturing processes / information technology enhancements / manufacturing errors / consumer products / expanded existing networks / radiological health products / radiological products / information to assess device / surgical imaging systems / device technologies / manufacturing / x-ray equipment / preapproval quality manufacturing facility inspections / premarket applications / active devices / large paper-based systems / colon cancer diagnostic devices / inspecting radiation emitting products / /
MedicalCondition
sterility / bacterial meningitis / metastatic breast cancer / recurrent breast cancer / breast cancer / cancer / malaria / President’s Pandemic Influenza / breast and colon cancer / HIV/AIDS / infectious disease / /
MedicalTreatment
neurosurgery / surgery / Radiation / open heart surgery / cochlear implant / /
Organization
CDRH TPLC / Food and Drug Administration / office of Regulatory Affairs / Expanded Electronic Government / Center for Devices / Medicare / American Society for Testing and Materials / Congress / office of Criminal Investigations / Radiological Health / FDA / Homeland Security’s Customs and Border Protection Service / Standard Establishment Data Service / Department of Homeland Security / Department of Health and Human Services / CDRH’s MQSA / /
Position
President / high contractor / /
Product
FY / /
Technology
Radiation / x-ray / information technology / ultrasound / microwave / health care technology / device technologies / MRI / lasers / magnetic resonance imaging / neurosurgery / device technology / /